Cetus's costly stumble on IL-2.
Culliton
B J
BJ
D001709:Biotechnology; D002292:Carcinoma, Renal Cell / Q000188:drug therapy; D004345:Drug Industry; D006801:Humans; D007376:Interleukin-2 / Q000009:adverse effects / Q000627:therapeutic use* / Q000633:toxicity; D007680:Kidney Neoplasms / Q000188:drug therapy; D014481:United States; D014486:United States Food and Drug Administration
D007376:Interleukin-2